Gabi Heller
@g-heller.bsky.social
Drugging intrinsically disordered proteins Co-Founder/CEO/CSO, Bind Research PI, eXtreme Dynamics & Therapeutics Lab, UCL (she/her)
Disordered proteins play key roles in disease but remain largely out of reach for drug discovery. The prevailing assumption is that they are undruggable. At Bind, we ask what it would take to make them druggable at scale. See our white paper and accompanying COSB below.
We’re looking for fellow nerds to help us make disordered proteins druggable. Love #IDPs, #MD, #NMR, #AI, #DrugDiscovery, or #MassSpec? Let’s talk. @bindresearch.org is hiring across the board: bindresearch.org/careers/ #compchem #compbio #NMRChat #TeamMassSpec #chemjobs @chemjobber.bsky.social
Careers
Careers
bindresearch.org
Delighted to announce @tlhr.bsky.social, @g-heller.bsky.social and I are building the UK’s first FRO @bindresearch.org with the goal of making disordered proteins druggable. Interested in doing breakthrough open science in an innovative organisation in Central London? We’d love to hear from you!
Incredibly excited to be starting @bindresearch.org with @gogs-k.bsky.social and @g-heller.bsky.social! We are a not-for-profit research startup based in London, creating tools and datasets to make disordered proteins druggable.
Today @gogs-k.bsky.social, @tlhr.bsky.social, and I are launching @bindresearch.org, a UK-based not-for-profit research startup to deliver publicly–available tools and datasets to make intrinsically disordered proteins druggable. 🍝 💊🧲 💻 🦠
